IMARC Group, a leading market research company, has recently releases report titled “Transdermal Skin Patches Market Report by Type (Single-layer Drug-in-Adhesive, Multi-layer Drug-in-Adhesive, Matrix, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Stores), Application (Pain Relief, Smoking Reduction and Cessation Aid, Overactive Bladder, Hormonal Therapy, and Others), and Region 2024-2032”, Offers a comprehensive analysis of the industry, which comprises insights on the transdermal skin patches market share.
How Big Is the Transdermal Skin Patches Market?
The global transdermal skin patches market size reached US$ 7.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 11.2 Billion by 2032, exhibiting a growth rate (CAGR) of 3.9% during 2024-2032.
Industry Overview of Transdermal Skin Patches
Transdermal skin patches refer to medical devices designed to deliver medication through the skin and into the bloodstream. They are made of a thin, flexible material that adheres to the skin and contains a specific amount of medication. They aid in slowly releasing the medicine through the skin into the bloodstream and provide a consistent dose of the drug. At present, they are used to deliver a variety of medications for pain relief, hormonal therapy, nicotine replacement therapy, and overactive bladder.
For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/transdermal-skin-patches-market/requestsample
What are the growth prospects and trends in the transdermal skin patches industry?
Presently, the growing geriatric population and increasing demand for non-invasive treatments represent one of the key factors positively influencing the market. In addition, the increasing prevalence of chronic diseases, such as diabetes, hypertension, and cardiovascular disorders, are catalyzing the demand for transdermal skin patches for managing these conditions as they provide a consistent and reliable dose of medication over an extended period.
Moreover, the rising popularity of transdermal nicotine patches among people who are trying to quit smoking is creating a favorable market outlook. Besides this, key market players are introducing biodegradable microneedle patches for transdermal delivery, which is contributing to the market growth.
Furthermore, governments of various countries are taking favorable initiatives to improve drug delivery and reduce healthcare costs, which is stimulating the market growth.
Leading Companies Operating in the Global Transdermal Skin Patches Industry:
- 3M Company
- AdhexPharma
- LTS Lohmann Therapie-Systeme AG
- Luye Pharma Group
- Medherant Limited
- Nitto Denko Corporation
- Noven Pharmaceuticals Inc. (Hisamitsu Pharmaceutical Co. Inc.)
- Prosolus Inc.
- Samyang Holdings Corporation
- Tapemark
- Teikoku Pharma USA Inc. (Teikoku Seiyaku Co. Ltd)
- tesa SE (Beiersdorf AG)
- Teva Pharmaceutical Industries Ltd.
Transdermal Skin Patches Market Report Segmentation:
The report has segmented the market into the following categories:
Breakup by Type:
- Single-layer Drug-in-Adhesive
- Multi-layer Drug-in-Adhesive
- Matrix
- Others
Breakup by Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Stores
Breakup by Application:
- Pain Relief
- Smoking Reduction and Cessation Aid
- Overactive Bladder
- Hormonal Therapy
- Others
Breakup by Region:
- North America: (United States, Canada)
- Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico, Others)
- Middle East and Africa
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163
